Picture of Mustang Bio logo

MBIO Mustang Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Mustang Bio Reports Full-Year 2020 Financial Results And Recent Corporate Highlights

March 24 (Reuters) - Mustang Bio Inc  MBIO.O :
    * MUSTANG BIO REPORTS FULL-YEAR 2020 FINANCIAL RESULTS AND
RECENT
CORPORATE HIGHLIGHTS
    * MUSTANG BIO INC - AS OF DEC 31, 2020, CO'S CASH AND CASH
EQUIVALENTS AND RESTRICTED CASH TOTALED $98.8 MILLION
    * MUSTANG BIO INC - EXPECTS TO FILE AN IND IN Q2 OF 2021 FOR
ITS
PIVOTAL MULTICENTER PHASE 2 CLINICAL TRIAL OF MB-207

Source text for Eikon:  ID:nGNX6mgGFL 
Further company coverage:  MBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Mustang Bio

See all news